» Articles » PMID: 26253293

Somatisation As a Risk Factor for Incident Depression and Anxiety

Overview
Journal J Psychosom Res
Specialty Psychiatry
Date 2015 Aug 9
PMID 26253293
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: In this study, we aimed to examine somatisation as a risk factor for the onset of depressive and anxiety disorders.

Methods: 4-year follow-up data from the Netherlands Study of Depression and Anxiety (NESDA), a multisite cohort study of the course of depression and anxiety, was analysed. Participants (18-65 years) without a lifetime depressive or anxiety disorder at baseline were included (n=611). Somatisation was measured at baseline with the somatisation subscale of the 4 Dimensional Symptoms Questionnaire. Onset of depression and anxiety was assessed with the CIDI interview at 2-year and 4-year follow-up.

Results: Somatisation was a risk factor for the incidence of depression [Hazard Ratio per unit increase (HR); 95% Confidence Interval (CI): 1.13; 1.09-1.17] and anxiety [HR; 95% CI: 1.14; 1.09-1.18]. Associations attenuated but remained statistically significant after adjusting for socio-demographic characteristics, chronic somatic disorders, and baseline levels of (subclinical) depressive or anxiety symptoms [adjusted HR for depression; 95% CI: 1.06; 1.00-1.12, adjusted HR for anxiety; 95% CI: 1.13; 1.07-1.20].

Conclusion: Persons who somatise have an increased risk of becoming depressed or anxious in subsequent years, over and above baseline levels of depressive or anxiety symptoms. They may represent a target group for prevention of depressive and anxiety disorders.

Citing Articles

Poverty, Somatisation Tendency and Potency in Low-Income Adolescent Groups of India and Israel: Explorations from the Field.

Banerjee S, Lev-Wiesel R, De S Children (Basel). 2023; 10(7).

PMID: 37508601 PMC: 10377797. DOI: 10.3390/children10071104.


Effectiveness of a blended multidisciplinary intervention for patients with moderate medically unexplained physical symptoms (PARASOL): A cluster randomized clinical trial.

van Westrienen P, de Wit N, Toonders S, Veenhof C, Gerrits M, Pisters M PLoS One. 2023; 18(4):e0283162.

PMID: 37023095 PMC: 10079131. DOI: 10.1371/journal.pone.0283162.


A Network Model of Positive Resources, Temperament, Childhood Trauma, and Comorbid Symptoms for Patient with Depressive Disorders.

Huh H, Lee S, Lee S, Chae J Psychiatry Investig. 2021; 18(3):214-224.

PMID: 33685037 PMC: 8016691. DOI: 10.30773/pi.2020.0187.


The burden of depressive disorders in musculoskeletal diseases: is there an association between mood and inflammation?.

Chimenti M, Lavinia Fonti G, Conigliaro P, Triggianese P, Bianciardi E, Coviello M Ann Gen Psychiatry. 2021; 20(1):1.

PMID: 33397417 PMC: 7783979. DOI: 10.1186/s12991-020-00322-2.


Cross-sectional study of aggression against Spanish nursing personnel and effects on somatisation of physical symptoms.

Perez-Fuentes M, Molero Jurado M, Martos Martinez A, Simon Marquez M, Ruiz N, Gazquez Linares J BMJ Open. 2020; 10(3):e034143.

PMID: 32152167 PMC: 7064063. DOI: 10.1136/bmjopen-2019-034143.